雌激素和γ-干扰素对去卵巢大鼠HPG轴中细胞凋亡的影响
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
下丘脑-垂体-性腺轴(Hypothalamic-Pituitary-gonad Axial, HPG轴)是机体重要的神经生殖调控轴。种类繁多、作用机制复杂的细胞因子、神经递质、激素及其受体之间的平衡是维持动物HPG轴神经免疫内分泌机能平衡的物质基础,其中任何物质表达失衡,都会打破HPG轴的平衡,引起一系列组织结构和功能的改变,进而引发细胞的衰老凋亡。为了探讨激素和细胞因子对HPG轴因雌激素缺乏所引起的组织功能改变和细胞衰老凋亡的调节作用,本试验拟通过建立去卵巢(OVX)大鼠模型,人为破坏HPG轴中神经-免疫-内分泌网络间的平衡状态,用免疫组织化学SP法来研究在这种病理状态下下丘脑和垂体中凋亡相关蛋白Bcl-2和Bax的表达情况以及体外补充雌激素(Estrogen,E)和细胞因子γ-干扰素(Interferon-γ, IFN-γ)后对其表达的影响。主要结果如下:
     1.大鼠下丘脑中Bcl-2和Bax的表达:大鼠下丘脑视上核、室旁核、弓状核、下丘脑腹内侧核及乳头体内侧核等35个核团中均有Bcl-2和Bax免疫反应阳性产物的表达,主要在细胞膜、细胞质和核膜分布。去卵巢后,Bcl-2的相对表达量随时程逐渐减少,4周后最少,6周后又逐渐上升,并且维持在一定的水平;Bax则逐渐增加,4周后达峰值,与假手术(SHAM)组差异均显著(P<0.05)。给予外源性雌激素后,Bcl-2的相对表达量增加,与OVX组差异显著(P<0.05);Bax的相对表达量在不同的核团出现不同程度的变化,在视上核、弓状核等核团Bax的相对表达量显著减少,与OVX差异显著(P<0.05),而在室旁核、下丘脑腹内侧核等核团Bax的变化则不显著,与OVX相比P>0.05。雌激素联合200 IUγ-干扰素注射,各核团内Bcl-2的相对表达量较OVX组差异极显著(P<0.01),与OVX+E2组差异显著(P<0.05),与SHAM组相比,P>0.05;Bax的含量总体变化趋势与单独注射雌激素后一致,表达量减少的核团与OVX组相比,差异也极显著(P<0.01);雌激素联合50 IU和800 IU的γ-干扰素,Bcl-2和Bax的相对表达量与OVX+E2差异不显著(P>0.05)。
     2.大鼠垂体内Bcl-2和Bax的表达:腺垂体和神经垂体内均有Bcl-2和Bax阳性细胞的表达,主要在细胞膜、细胞质着色,腺垂体内阳性产物明显较神经垂体内多,着色也深。去卵巢后,Bcl-2的表达减少,Bax增加,与SHAM组差异显著(P<0.05)。补充外源性雌激素后,Bcl-2较OVX组显著增加(P<0.05),Bax显著减少(P<0.05);雌激素联200IUγ-干扰素注射后,凋亡情况较单独注射雌激素有所改善,Bcl-2的表达较OVX组极显著增加(P<0.01),Bax极显著减少(P<0.01),两者与SHAM组差异均不显著(P>0.05)。50 IU/800 IU的γ-干扰素联合雌激素注射后凋亡情况与单独注射雌激素后差异不显著(P>0.05)。
     以上结果表明,雌激素缺乏状态下,下丘脑和垂体中的细胞对凋亡的敏感性增强,而外源性的生理剂量的雌激素与适当剂量的γ-干扰素对下丘脑神经元和垂体在一定时期内有重要的保护作用,可以调节Bcl-2和Bax蛋白的表达和两者的比例。
Hypothalamic-Pituitary-gonad (HPG) axis is important to regulation mechanisms of neuroreproduction. The balance of a great variety cytokines, neurotransmitters and hormones and their receptors with complex coordination mechanisms is the basic to matain the balance of immune-nero-endocrine network. If the expressions of the matters above-mentioned lose balance, the structure and effunction of the tissue may vary, and then the cells may ageing and apoptosis. In order to study the regulation mechanisms of hormones and cytokines to this variation for estrogen deficiency, ovariectomizedrat (OVX) modelwas made and sensitive immunohistochemical SP method was used to study the expressions of the apoptosis associated protein Bcl-2 and Bax in this pathologic state and in the state of treated with 17-βestrogen and Interferon-γ( IFN-γ). The main rusults were as followed:
     1. The expressions of Bcl-2 and Bax in hypothalami of rat: In 35 nucleuses in hypothalamus of the rats, include supraoptic nucleus, periventricular nucleus, arcuatus nucleus, hypothalamic ventromedialis nucleus and medial mamillary nucleus, et al, Bcl-2 and Bax immunohistochemical positive substances were located in these nucleuses and main located in cellular membrane, cytoplasm and caryotheca. After ovariectomized, relative expresions of Bcl-2 positive productions(μ2) tapered with the cours and to be the minumum after 4 weeks, concurrently, theμ2 of Bax increased, and to be the maximum after 4 weeks, which had significant difference with the SHAM group(P<0.05). After treated with 17-βestrogen, theμ2 of Bcl-2 increased and had remarkable difference with OVX group(P<0.05), but theμ2 of Bax had different in different nucleus, it decreased significantly in supraoptic nucleus, arcuate nucleus,et al, which had remarkable difference with OVX group(P<0.05); and it had no significant variation in periventricular nucleus, hypothalamic nucleus,et al. After treated with 17-βestrogen and 200 IU IFN-γtogether, theμ2 of Bcl-2 had very significant difference with OVX group(P<0.01), and had significant difference with OVX+E2 group(P<0.05),but had no remarkble difference with SHAM group(P>0.05). The total tendency of theμ2 of Bax was the to OVX+E2 group, it also had very significant difference with OVX group(P<0.01) in the nucleus which theμ2 of Bax decreased. Compared with OVX +E2 group, theμ2 of Bcl-2 and Bax of the grouop treated with 17-βestrogen and 50 IU/800 IU IFN-γtogether had no significant difference (P>0.05).
     2. The expressions of Bcl-2 and Bax in pituitary of rat: Bcl-2 and Bax immunohistochemical positive substances were located in both and neurohypophysis in cellular membrane, cytoplasm.The number of Bcl-2 and Bax positive products in neurohypophysis is obviously less than that in adenohypophysis . After ovariectomized, relative expresions of Bcl-2 positive productions(μ2) tapered with the cours and to be the minumum after 4 weeks, concurrently, theμ2 of Bax increased, and to be the maximum after 4 weeks, which had significant difference with the SHAM group(P<0.05). After treated with 17-βestrogen, theμ2 of Bcl-2 increased and had remarkable difference with OVX group(P<0.05), and theμ2 of Bax decreased and had significant difference with OVX group(P<0.05) too. After treated with 17-βestrogen and 200 IU IFN-γtogether, theμ2 of Bcl-2 had very significant difference with OVX group(P<0.01), and had significant difference with OVX+E2 group(P<0.05),but had no remarkble difference with SHAM group(P>0.05). The total tendency of theμ2 of Bax was the to OVX+E2 group, it also had very significant difference with OVX group(P<0.01) in the nucleus which theμ2 of Bax decreased. Compared with OVX +E2 group, theμ2 of Bcl-2 and Bax of the grouop treated with 17-βestrogen and 50 IU/800 IU IFN-γtogether had no significant difference (P>0.05).
     The result aboved indicate that the cells of hypothalami and pituitary were more sensitive to the apoptosis in the state of lacking estrogen. Ectogenic physiological dose estrogen and proper does IFN-γhave important protected effect on the hypothalami neuron and pituitary in a certain period, which can regulating the express and the ratio of the contents of Bcl-2 and Bax.
引文
[1] 李继硕.神经科学基础[M].北京:高等教育出版社,2002.
    [2] 王建辰,张孝荣.动物生殖调控[M].合肥:安徽科学技术出版社,1998.
    [3]朱长庚.免疫-神经-内分泌网络[J].解剖学报,1993,24(2):216~221.
    [4] Besedovsky HO, Del Rey, Sorkin E. Immune-neuroen-docrineinteractions[J]. J Immunol,1985, 35:750~753.
    [5] Brown R, Li Z, Vriend CY, et al. Suppression of splenic macrophage interleukin-1 secretion following intracerebroventricular injection of interleukin-1: evidence of sympathetic control [J].Cellimmunol, 1991, 132:84~88
    [6] 谢启文主编.现代神经内分泌学[M].]上海:上海医科大学出版社,1999:351~366.
    [7] 陆德源.现代免疫学[M].上海:上海科学技术出版社,1998.
    [8] 常青, 应大君, 史常旭. 雌激素对下丘脑神经元结构及雌激素受体表达水平的影响[J]. 第三军医大学学报, 2001, 23(3): 318~320.
    [9] 邓小华, 蔡维君, 杜亚政, 等. 大鼠下丘脑视前区神经元内雌激素受体 α 的表达-免疫组织化学研究[J]. 中国组织化学与细胞化学, 2001,10(4):383~386.
    [10] 赵慧英,孙建红,徐永平,等.IFN-γ免疫反应产物在怀孕早期山羊下丘脑-垂体-性腺轴的表达[J].西北农林科技大学学报,2006,34(8):35~38.
    [11] 张 庆 红 , 陈 亚 琼 , 胡 玉 珍 , 等 . 雌 激 素 受 体 在 大 鼠 垂 体 前 叶 的 分 布 [J]. 解 剖 学报,2001,32(4):352~354.
    [12] 胡格,穆祥,陈树林,等.大鼠垂体前叶内 IFN-γ 免疫阳性神经纤维的分布[J].畜牧兽医学报,2002,33(6):559~561.
    [13] 赵慧英,卿素珠,孙建红,等.ER 免疫反应产物在幼龄公山羊下丘脑-垂体-性腺轴的表达[J].中国兽医学报,2005,25(1):46~47.
    [14] Fabio S , Daniel HB , Jonna F , et al. Transcriptional profiling of estrogen regulated gene expression via estrogen receptor(ER)α or ERβ in human osteosarcoma cells : distinct and common target genes for there receptors[J]. Endocrinology , 2004,145(7):3473~3861.
    [15] Sudha WM , Elena H , Joel Y, et al . Immunolocalization of estrogen receptorβ in the mouse brain : comparison with estrogen receptor α [J] . Endocrinology ,2003,144(5) : 2055~2067. [16 时 青 云 , 闫 琦 . 雌 孕 激 素 与 免 疫 作 用 的 相 互 关 系 研 究 进 展 [J]. 新 乡 医 学 院 学 报 , 2000,17(1):71~73.
    [17] Pail F, Bibudhendra S. Metal replacement in Zine Finger and its Effect on DNA Binding[J]. Enverironmental heath perspectives ,2003 ,102 (3) :195~198.
    [18] Dechering K, Boersma C, Mosselaqman S. Estrogen receptors α and β:Two receptors of a kind[J]. Current Med Chem,2000 ,7(5) :561~576.
    [19] Gehm BD , McAndrews JM, Jordan VC , et al. EGF activates highly selective estrogen responsive reporter plasmids by an ER independent pathway[J]. Mol Cell Endocrinol ,2004 ,159(1) :53~62.
    [20] Resnick EM , Schreihofer DA , Periasamy A , et al. Truncated estrogen receptor product suppresses estrogen receptor transactivation by dimerization with estrogen receptors α and β[J]. BiolChem,2000 ,58 :391~448.
    [21] Green S, Walter P, Kumar V, et al. Human estrogen receptor cDNA:sequence,espression and homology to verb [J]. Nature ,2003 ,20 (13) :134~139.
    [22] Bord S , Homer A, Beavan S, et al. Estrogen receptors alpha and beta are differentially expressed in developing human bone[J]. Clin Endocrinol Metab,2001,86(5) :2309~2341.
    [23] Muramatsu M, Inoue S. Estrogen receptors :How do they control reproductive and nonreproductive functions[J]. Biochem Biophys Res Commun ,2000 ,270(1) :1~10.
    [24] Ogawa S, Hosoi T, Shiraki M, et al. Association of estrogen receptor β gene plolymorphism with bone mineral density[J]. Biochem Biophys Res Common ,2000 ,269(2) :527~541.
    [25] Tong D, Schuster E, Seifert M, et al. Expression of estrogen receptor β is forms in human breast cancer [J]. Treat ,2002. 71(3) :249~255.
    [26] 黄朝晖,王金福. ERβ—一种新型的雌激素受体[J]. 生命科学,2000 ,12 (3) :1296~1298.
    [27] 孙桂英,金志军,杨云纺. 雌激素受体的变异及其临床意义[J]. 国外医学妇产科分册,1999,26 (3) :159~161.
    [28] Davis VL , Chan CC , Schoen TJ , et al. An estrogen receptor repressor induces cataract formation in transgenic mice[J] . Proc Natl Acad Sci USA ,2002 ,99 (14) :9427~9432.
    [29] Peach K, Webb P , George G, et al. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites[J] . Science ,1997 ,277 :1508~1511.
    [30] 张波,陈道达,王国斌,等.乳腺癌雌激素受体mRNA的变异剪切与Tamoxifen耐受[J]. 华中科技大学学报(医学版),2003 ,32 (1) :46~50.
    [31] 徐春,李江源,黄兆坚.雌激素受体基因在乙底酚诱发的大鼠催乳素瘤中的表达[J]. 中华内分泌代谢杂志,2001 ,17 (1) :47~50.
    [32] Fan S , Wang JA , Yuan R , et al. BRC-1 inhibition of estrogen receptor signaling in transfected cells[J] . Science. 1999 ,284 :1354~1356.
    [33] Taylor AP, Osorio L, Craig R, et al. Tumor2specific regulation of angiogentic growth factors and their receptors during recovery from cytotoxic therapy[J] . Clin Canc Res ,2002 ,8 (4) :1213~1222.
    [34] 桂黎明,王建六,魏丽惠.雌激素受体与细胞信号传导通路[J]. 国内医学分子生物学分册,2001,23 (2):103~105.
    [35] Herry DM, Kalkhoven E, Hoare S, et al. A signature motif in transcriptional coactivators mediates binding to nuclear receptors[J]. Nature ,1998 ,387 :733~736.
    [36] Feng W J, Riberiro R J, Wanger R, et al. Hormone development coactivator binding to a hydrophobic cleft on nuclear receptors [J] . Science ,1998 ,280 :1747~1749.
    [37] Yasutomi K, Xu L, Thorsten H, et al. ACBP integrator complex mediates transcriptional activation and AP21 inhibition by nuclear receptors[J]. Cell ,1996 ,85 :403~414.
    [38] Zwijsen RM, Buckle RS, Hijmans M, et al. Ligand independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1[J] . Genes Dev ,1998 ,12 :3488~3498.
    [39] Chi L , Tsao M. Protonogen and growth factor/ receptor expression in the establishment of primary human nonsmall cell lung carcinoma cell lines[J] . Am J Pathol ,1993 ,142 :413~423.
    [40] Thompson MC, Lynch IJ, Bhardwaj B. Expression of estrogen receptor subtypes and Erβ is forms in colon cancer [J] . Cancer Research ,2001 ,61 :632~640.
    [41] Beyer K, Jun T,Masaomi K, et al. Estrogen promotes differentiation and survival of dopaminergicneurons derived from human neural stem cells [J]. Neurosis Res, 1997, (79 )279~286.
    [42] Royuela M, de-Miguel MP, Ruiz A, et al. Interferon-gamma and its functional receptors over expression in benign prostatic hyperplasia and prostatic carcinomas: parallelism with cmyc and p53 expression[J]. Eur Cytokine Netw, 2000,11:119~127.
    [43] 张吉强,蔡文琴. 雌激素-β 受体免疫阳性神经元在成年小鼠脑内的分布与性别差异[J]. 四川解剖学报, 2001,9 (1) :35~36.
    [44] Rissman EF, Heck AL, Leonard JE, et al. description of estrogen receptor beya gene impairs spatial leaming in female mice [J]. Proc Natl Acad Sci USA, 2002,99(6):3396
    [45] Wang L, Andersson S, Warner M, et al. Estrogen receptor(ER)beta knockout mice reveal a role for ERbeta in migration of cortical neurons in the developing brian [J]. Proc Natl Acad Sci USA,2003,100(2):703.
    [46] 张馨,周建军,徐运.雌激素脑保护的基因和非基因机制学说[J]. 中国临床康复,2005,9(5:143~145.
    [47] 马兰,张一娜,李颖.雌激素对大脑皮质细胞的神经保护作用[J]. 中国临床康复,2004, 8(7):1280~1283.
    [48] 徐杰,邵正仁,戴忠辉,等.雌二醇对缺血性脑损伤的保护作用[J]. 解剖学研究,2000,22(1):35~36,42.
    [49] 寇宗莉,李茂欣,汤旭磊,等. 雌激素对去卵巢大鼠记忆功能脑海马部位Aβ1-40及PKC表达的影响[J]. 中国老年学杂志,2004,24(4):350~352.
    [50] Weilind Nq. Estradio selectively regulates agonist binding sites on the N-methy Daspartate receptor complex in the CAI region of the hippocampus[J]. Endocrinology, 1992, 131: 662~668.
    [51] 赵宇红,黄 韧,徐 杰,等. 雌二醇对海马神经元和隔区胆碱能神经元损伤的保护作用比较[J]. 中国临床康复,2005,9(1):77~80.
    [52] Mylonas I, Jeschke U, Shabani N, et al. Immunohistochemical analysis of estrongen receptor alpha, estrogen receptor beta and progesterone receptor in normal human endometrium [J]. Acta Histochem, 2004,106(3):245~252.
    [53] Fu X, Rezapour M, Xu X. Expression of estrogen receptor- alpha and beta in anterior vaginal walls of genuine stress incontinent woman [J]. Int Urogynecol J,2003,14:276~279.
    [54] Carreau S, Bourguiba S, Lambard S,et al. Reproductive system:aromatase and estrogens[J]. Mol Cell Endocrinol,2002, 193:137~143.
    [55] Kiefer R, Keuteber GW. Distribution of interferon in rat nervous system [J]. Neuroeology, 1990, 37 (3): 725~732.
    [56] Nakamura L. Expression of interferon-γ in rat nerous system[J]. Neuroeology,1994,45(6):75~83.
    [57] Chao CC, Sheng WS. Lytokine-stimulate astrocytes damage human neurous viaanitric oxide mechanism[J]. J Cline, 1996, 16:276~284.
    [58] 徐天乐,张远强.细胞因子对内分泌的影响[J]. 国外医学分册,1992,12 (3):113~116.
    [59] Mu J, Abe Y, Tsutsui T, et al. Inhibition of growth and metastasis of cow carcinoma by administering a drug capable of interfering with vascular endothelial growth factor activity. Jpn[J]. Cancer Res,1996, 87: 963~71.
    [60] 赵芳,罗荣祥,马魁榕等. IFN-α 和 IFN-γ 对灌流假孕大鼠卵巢黄体的作用[J]. 动物学报,1996, 42 (4):401~407.
    [61] 张翔,沈维雄,孙志达,等.前列腺索和 γ-干扰素对人黄体细胞甾体激素生成的影响及相互作用[J].生殖与避孕,1995,16(5):343~350.
    [62] 夏红飞,郝艳红.妊娠大鼠子宫和胎盘 IL-1β 表达及 IFN-γ 对其表达的影响[J]. 动物学报,2004, 50 (1) :48~54.
    [63] Tsujimoto Y. Cell death regulation by the Bcl-2 protein family in the mitochondria[J]. J Cell Physiol ,2003 ,195 (2) :158~167.
    [64] Petros AM, Medek A, Nettesheim DG, et al. Solution structure of the antiapoptotic protein Bcl-2[J] . Proc Natl Acad Sci USA , 2001 , 98(6):3012~3017.
    [65] Huang Q , Petros AM, Virgin HW. Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus[J] . Proc Natl Acad Sci USA , 2002 , 99(6) :3428~3433.
    [66] Muchmore SW, Sattler M, Liang H, et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death[J]. Nature ,1996, 381(6580) :335~341.
    [67] Aritomi M, Kunishima N, Inohara N, et al. Crystal structure of rat Bcl-xL Implications for the function of the Bcl22 protein family[J] . J Biol Chem ,1997, 272(44) :27886~27892.
    [68] Denisov AY, Madiraju MS, Chen G, et al. Solution Structure of Human BCL-2 w: modulation of ligand binding by the cterminal helix [J] . J Biol Chem , 2003 , 278 (23) : 21124~21128.
    [69] Suzuki M, Youle RJ, Tjandra N. Structure of Bax : coregulation of dimer formation and intracellular localization [J] . Cell , 2000 , 103(4) :645~654.
    [70] Chou JJ, Li H, Salvesen GS, et al. Solution structure of BID, an intracellular amplifier of apoptotic signaling [J]. Cell ,1999, 96(5) :615~624.
    [71] McDonnell JM, Fushman D, Milliman CL, et al. Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists [J]. Cell, 1999, 96(5) :625~634.
    [72] Fan J, Zhang Q, Tochio H, et al. Structural basis of diverse sequence-dependent target recognition by the 8 kDa dynein light chain[J]. J Mol Biol, 2001, 306(1) :97~108.
    [73] Yin XM, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax [J]. Nature, 1994, 369 (6478) :321~323.
    [74] Sattler M, Liang H, Nettesheim D, et al. Structure of Bcl-xL/Bak peptide complex:recognition between regulators of apoptosis[J]. Science , 1997, 275(5302) :983~986.
    [75] Petros AM, Nettesheim DG, Wang Y, et al. Rationale for Bcl-xL/Bad peptide complex formation from structure , mutagenesis and biophysical studies[J]. Protein Sci , 2000 , 9(12) :2528~2534.
    [76] Borner C. The Bcl-2 protein family:sensors and checkpoints for life-or-death decisions[J]. Mol Immunol ,2003 ,39 (11) :615~647.
    [77] De Falco M, Laforgia V, Fedele V. Vasoactive intestinal peptide stimulation modulates the expression of Bcl-2 family members in the adrenal gland of the lizard Podarcis sicula[J]. HistochemJ,2001,33 (11~12) :639~645.
    [78] Raisova M, Hossini AM, Eberle J. The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/ Fas-mediated apoptosis[J]. J Invest Dermatol ,2001 ,117(2) :333~340.
    [79] Shangary S, Johnson DE. Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death[J]. Biochemistry ,2002 ,41 (30) :9485~9495.
    [80] Moreau C, Cartron P F, Hunt A. MinimalBH3peptides promote cell death by antagonizingant-apoptotic proteins [J]. J Biol Chem,2003 ,278(21) :19426~19435.
    [81] Tsujimoto Y. Cell death regulation by the Bcl-2 protein family in the mitochondria[J]. J Cell Physiol, 2003, 195 (2) :158~167.
    [82] Kroemer G. Mitochondrial control of apoptosis : an overview [J]. Biochem Soc Symp ,1999 ,66 :1~15.
    [83] Crompton M. Mitochondrial intermembrane junctional complexes and their role in cell death[J]. J Physiol ,2000 ,529[1] :11~21.
    [84] Harris MH, Thompson CB. The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability[J]. Cell Death Differ ,2000,7 (12) :1182~1191.
    [85] Kuwana T, Mackey MR, Perkins G. Bid,Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane[J]. Cell ,2002 ,111 (3) :331~342.
    [86] Mayer B, Oberbauer R.Mitochondrial regulation of apoptosis[J]. News Physiol Sci ,2003 ,18 :89~94.
    [87] Mikhailov V, Mikhailova M, Pulkrabek DJ. Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane[J ]. J Biol Chem, 2001 ,276 (21) :18361~18374.
    [88]孙健红,张涌,郑月茂,等. ERα 免疫反应产物在山羊卵巢中的分布[J]. 畜牧兽医学报2006,37(9):920~923.
    [89] 李延清. IFN-γ 与免疫-神经-内分泌网络的相互关系[J]. 延安大学学报(自然科学版),2003,22(3):24-26.
    [90] 张翔,沈维雄,孙志达,等.前列腺素和 γ-干扰素对人黄体细胞甾体激素生成的影响及相互作用[J].生殖与避孕,1995,16(5):343~350.
    [91] Howataon AG, Fraguharson M, Meager A, et al. Localization of α-interferon in human feto-piac-ental unit[J]. Endocrionl,1988,119:531~-534.
    [92] 赵慧英,卿素珠,孙健红,等. ER 免疫反应产物在幼龄公山羊下丘脑-垂体-性腺轴的表达[J]. 中国兽医学报,2005,25(1):46~47.
    [93] 赵慧英,孙健红,徐永平,等.IFN-γ免疫反应产物在怀孕早期山羊下丘脑-垂体-性腺轴的表达[J]. 西北农林科技大学学报,2006,34(8):35~38.
    [94] 何书海,赵慧英,乐涛,等.IFNR 和 ER 在大鼠下丘脑-垂体-卵巢轴中的共表达[J]. 西北农林科技大学学报,2007,35(11):33~36.
    [95] 洪颖.卵巢切除与更年期综合征的关系[J]. 中国实用妇科与产科杂志,1996 ,12(6):350~352.
    [96] 焦润生,姚兰春,金香兰,等.外源性雌激素对去卵巢大鼠抗氧化能力及海马神经元线粒体的影响[J]. 哈尔滨医科大学学报,2006,40(1):10~12.
    [97] 谭宁,孟艳,姬志娟,等.卵巢去势引起神经细胞凋亡及凋亡相关蛋白改变与 UPAN 的作用[J].中国药理学通报,2003,19(7):787~790.
    [98] 吕 建,陈智超,吕秋柏,等.干扰素和小剂量阿糖胞苷联合作用诱导 K562 细胞凋亡[J]. 华中科技大学学报(医学版),2006,35(3):336~338.
    [99] Jewell AP, Worman CP, Lyayard PM, et al. Serum macrophage colony-stimulating factor (M-CSF) levels correlate with clinical response to interferon-alpha in patients with early-stage B-CLL[J]. Br J Haematol,1994,86(2):441~443.
    [100] Panayiotidis P, Ganeshaguru K, Jabbar SA, et al. Alpha-interferon (alpha-IFN) protects B-chronic lymphocytic leukaemia cells from apoptotic cell death in vitro[J]. Br J Haematol, 1994, 86(1):169-173.
    [101] Jewell AP. Interferon-alpha, Bcl-2 expression and apoptosis in B-cell chronic lymphocyticleukemia[J]. Leuk-Lymphoma, 1996, 21(1-2):43-47.
    [102] 常青,应大君,史常旭. 雌激素对下丘脑神经元结构及雌激素受体表达水平的影响[J]. 第三军医大学学报,2001,23(3):318~320.
    [103] 邓小华, 蔡维君, 杜亚政, 等. 大鼠下丘脑视前区神经元内雌激素受体 α 的表达-免疫组织化学研究[J]. 中国组织化学与细胞化学,2001,10(4):383~386.
    [104] Weinberg RA. The Biology of Cancer [M]. Garland Science, New York, 2007, 307~356.
    [105] Liu X, Zhu XZ. Roles of P53, c-Myc, Bcl-2, Bax and caspases in glutamate-induced neuronal apoptosis and the possible neuroprotective mechanism of basic fibroblast growth factor [J]. Brain Res Mol Brain Res, 1999, 71: 201~216.
    [106] Reed JC. Double identity for proteins of the Bcl-2 family [J]. Nature , 1997, 387 : 773~776.
    [107] Chen XW, Zhu SHL, Fan YH, et al. The effects of estrogen on the expression of Bcl-2 and Bax in the intracardic ganglionic neurons of the ovariectomized female rats[J]. Chinese Journal of Neuroanatomy, 2004, 20(5): 509~512.
    [108] Yukhananov RY. Handa RT. Estrogen alters proenkephalin RNAs in the paraven-tricular nucleus of the hypothalamus following stress[J]. Brain Res 1997,764(1-2):109~201.
    [109] Liu J SH, Guo KH, Lin GY, et al. Effects of estrogen on basal forebrain cholinergic neurons and Nitric Oxide Syntheses’ positive neurons to ovariectomized rats. China Academic Journal, 2002, 24(3): 200~203.
    [110] 姜桦,曹斌融. 细胞凋亡调控蛋白 Bcl-2/Bax 与子宫内膜异位症的关系[J]. 中国实用妇科与产科杂志,2004,20(4):246~248.
    [111] Suresh BP, Jenny MJ, Robert DK. Treatment of rats with 17-β estradiolor relax in rapidly inhibit suterine estrogen Receptor β1 and β2 messenger ribonucleicacid levels[J]. Biology of Reproduction, 2002, 67:1919~1926.
    [112] 胡昌东,归绥琪.自然流产患者滋养细胞肝素表皮生长因子的表达及意义[J]. 上海医学,2004,27(7):491~494.
    [113] Kondapaka SB, Fridman R, Reddy KB. Epidermal growth factor and amphiregulinup regulate matrixm etalloproteinase-9 in human breast cancer cell [J]. Int J Cancer, 1997, 70(6):722~725.
    [114] Alkayed NJ, Goto S, Sugo N, et al. Estrogen and Bcl-2:gene induction and effect of transgene in experimental stroke [J]. Neuroscience, 2001, 21 (19):7543~7550.
    [115] 陈倩,吴宗贵,张玲珍,等.γ-干扰素对平滑肌细胞增殖与凋亡及基质金属蛋白酶活性的影响[J].中国循环杂志,2003,18(4):306~309.
    [116] 王秋实,吴德金,孙凌宇,等.γ-干扰素对兔胆总管愈合过程中细胞增殖和转化的影响[J].肝胆胰外科杂志,2006,18(2):74~76.
    [117] 潘健,张胜权,陈兵.γ-干扰素在体外对血管内皮细胞凋亡的诱导作用[J].蚌埠医学院学报,2005,30(5):388~389.
    [118] 吕 建,陈智超,吕秋柏,等.干扰素和小剂量阿糖胞苷联合作用诱导 K562 细胞凋亡[J]. 华中科技大学学报(医学版),2006,35(3):336~338.
    [119] 李雪梅,孙抒,王建光,等.γ-干扰素对 MGC-803 胃癌细胞株诱导凋亡作用及其机制研究[J]. 临床医学,2005,25(1):5~8.
    [120] 程丽娜,杜桂珍,陈伯英.电针调整去卵巢大鼠下丘脑-垂体-卵巢轴异常功能的生化机制[J].上海针灸杂志,2001,20(6):33~35.
    [121]赵宏,田占庄,陈伯英. 去卵巢大鼠下丘脑-垂体-卵巢轴的功能代偿机制研究[J].中国神经科学杂,2003,19(4):229~233.
    [122]高慧,季士珠,陈伯英.电针促进去卵巢大鼠肾上腺增大,血皮质酮含量升高[J].针刺研究,1995,20(2):55~58.
    [123] Hall JM, Mcdonnell DP. The estrogen receptor-β (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogen and antiestrogen [J]. Endocrinology,1999,140 (12):5566~5578.
    [124] Nie W, Zhang YX. Role of estrogen in cognitive function and prevention of Neuronal loss in hippocampus [J]. Chinese Journal of Pharmacology and Toxicology, 2001,15(5):321~325.
    [125] Weinberg RA. The Biology of Cancer [M]. Garland Science, New York, 2007, 307~356.
    [126] Liu X, Zhu XZ. Roles of P53, c-Myc, Bcl-2, Bax and caspases in glutamate-induced neuronal apoptosis and the possible neuroprotective mechanism of basic fibroblast growth factor [J]. Brain Res Mol Brain Res, 1999, 71: 201~216.
    [127] Reed JC. Double identity for proteins of the Bcl-2 family [J]. Nature , 1997, 387 : 773~776.
    [128] Chen XW, Zhu SHL, Fan YH, et al. The effects of estrogen on the expression of Bcl-2 and Bax in the intracardic ganglionic neurons of the ovariectomized female rats[J]. Chinese Journal of Neuroanatomy, 2004, 20(5): 509~512.
    [129] Liu J SH, Guo KH, Lin GY, et al. Effects of estrogen on basal forebrain cholinergic neurons and Nitric Oxide Syntheses’ positive neurons to ovariectomized rats. China Academic Journal, 2002, 24(3): 200~203
    [130] 姜桦,曹斌融. 细胞凋亡调控蛋白 Bcl-2/Bax 与子宫内膜异位症的关系[J]. 中国实用妇科与产科杂志,2004,20(4):246~248.
    [131] 张 庆 红 , 陈 亚 琼 , 胡 玉 珍 , 等 . 雌 激 素 受 体 在 大 鼠 垂 体 前 叶 的 分 布 [J]. 解 剖 学报,2001,32(4):352~354.